Modulation of Intestinal Cholesterol Absorption by Dietary Tea Polyphenols

Polyphenols in Human Health and Disease

Volumn 1, Issue , 2013, Pages 625-638

  Kobayashi, Makoto ^a   Ikeda, Ikuo ^b  

^a H   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Absorption; Catechins; Cholesterol; Micellar solubilization of cholesterol; Tea; Theaflavins

Indexed keywords

EID: 84902568771     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-398456-2.00048-7     Document Type: Chapter

References (94)

1. Wu C.D., Wei G.X. Tea as a functional food for oral health. Nutrition 2002, 18(5):443-444.
2. Subramanian N., Venkatesh P., Ganguli S., Sinkar V.P. Role of polyphenol oxidase and peroxidase in the generation of black tea theaflavins. J Agric Food Chem 1999, 47(7):2571-2578.
3. Nakachi K., Matsuyama S., Miyake S., Suganuma M., Imai K. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 2000, 13(1-4):49-54.
4. Zhu Q.Y., Zhang A., Tsang D., Huang Y., Chen Z.Y. Stability of green tea catechins. J Agric Food Chem 1997, 45(12):4624-4628.
5. Su Y.L., Leung L.K., Huang Y., Chen Z.Y. Stability of tea theaflavins and catechins. Food Chem 2003, 83(2):189-195.
6. Chen Z.Y., Xhu Q.Y., Tsang D., Huang Y. Degradation of green tea catechins in tea drinks. J Agric Food Chem 2001, 49(1):477-482.
7. Seto R., Nakamura H., Nanjyo F., Hara Y. Preparation of epimers of tea catechins by heat treatment. Biosci Biotechnol Biochem 1997, 61(9):1434-1439.
8. Kuriyama S., Shimazu T., Ohmori K., Kikuchi N., Nakaya N., Nishino Y., et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 2006, 296(10):1255-1265.
9. Wang Z.M., Zhou B., Wang Y.S., Gong Q.Y., Wang Q.M., Yan J.J., et al. Black and green tea consumption and the risk of coronary artery disease: a meta-analysis. Am J Clin Nutr 2011, 93(3):506-515.
10. Hirano R., Momiyama Y., Takahashi R., Taniguchi H., Kondo K., Nakamura H., et al. Comparison of green tea intake in Japanese patients with and without angiographic coronary artery disease. Am J Cardiol 2002, 90(10):1150-1153.
11. Wen W., Xiang Y.B., Zheng W., Xu W.H., Yang G., Li H., et al. The association of alcohol, tea, and other modifiable lifestyle factors with myocardial infarction and stroke in Chinese men. CVD Prev Control 2008, 3(3):133-140.
12. Wang Q.M., Gong Q.Y., Yan J.J., Zhu J., Tang J.J., Wang M.W., et al. Association between green tea intake and coronary artery disease in a Chinese population. Circ J 2010, 74(2):294-300.
13. Lorenz M., Jochmann N., von Krosigk A., Martus P., Baumann G., Stangl K., et al. Addition of milk prevents vascular protective effects of tea. Eur Heart J 2007, 28(10):219-223.
14. Martin M.J., Browner W.S., Hulley S.B., Kuller L.H., Wentworth D. Serum cholesterol, blood pressure and mortality: implications from a cohort of 361,662 men. Lancet 1986, 2(8513):933-936.
15. Okamura T., Tanaka H., Miyamatsu N., Hayakawa T., Kadowaki T., Kita Y., et al. NIPPON DATA80 Research Group. The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis 2007, 190(1):216-223.
16. Jain K.S., Kathiravan M.K., Somani R.S., Shishoo C.J. The biology and chemistry of hyperlipidemia. Bioorg Med Chem 2007, 15(14):4674-4699.
17. Imai K., Nakachi K. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 1995, 310(6981):693-696.
18. Kono S., Shinchi K., Ikeda N., Yanai F., Imanishi K. Green tea consumption and serum lipid profiles: a cross-sectional study in Northern Kyushu, Japan. Prev Med 1992, 21(4):526-531.
19. Kono S., Shinchi K., Wakabayashi K., Honjo S., Todoroki I., Sakurai Y., et al. Relation of green tea consumption to serum lipids and lipoproteins in Japanese men. J Epidemiol 1996, 6(3):128-133.
20. Tokunaga S., White I.R., Tanaka K., Kono S., Tokudome S., Akamatsu T., et al. Green tea consumption and serum lipids and lipoproteins in a population of healthy workers in Japan. Ann Epidemiol 2002, 12(3):157-165.
21. Tubobo Y., Tsugana S. Green tea intake in relation to serum lipid level in middle-aged Japanese men and women. Ann Epidemiol 1997, 7(4):280-284.
22. Kajimoto O., Kajimoto Y., Yabune M., Nozawa A., Nagata K., Kakuda T. Tea catechins reduced serum cholesterol levels in mild and borderline hypercholesterolemis patients. J Clin Biochem Nutr 2003, 33:101-111.
23. Kajimoto O., Kajimoto Y., Takeda M., Nozawa A., Suzuki Y., Kakuda T. A beverage containing tea catechins with a galloyl moiety reduce serum cholesterol level in hypercholesterolemis womens. Health Sci 2006, 22:60-71. [in Japanese with English summary].
24. Davies M.J., Judd J.T., Baer D.J., Clevidence B.A., Paul D.R., Edwards A.J., et al. Black tea consumption reduces total and LDL cholesterol in mildly hypercholesterolemic adults. J Nutr 2003, 133(10):3298S-3302S.
25. Maron D.J., Lu G.P., Cai N.S., Wu Z.G., Li Y.H., Chen H., et al. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med 2003, 163(12):1448-1453.
26. Trautwein E.A., Du Y., Meynen E., Yan X., Wen Y., Wang H., et al. Purified black tea theaflavins and theaflavins/catechin supplements did not affect serum lipids in healthy individuals with mildly to moderately elevated cholesterol concentrations. Eur J Nutr 2010, 49(1):27-35.
27. Zheng X.X., Xu Y.L., Li S.H., Hui R., Huang X.H. Green tea intake lowers serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am J Clin Nutr 2011, 94(2):601-610.
28. Kim A., Chiu A., Barone M.K., Avino D., Wang F., Coleman C.I., et al. Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J Am Diet Assoc 2011, 111(11):1720-1729.
29. Nagao T., Meguro S., Hase T., Otsuka K., Komikado M., Tokimitsu I., et al. A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obesity (Silver Spring) 2009, 17(2):310-317.
30. Nagao T., Komine Y., Soga S., Meguro S., Hase T., Tanaka Y., et al. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J Clin Nutr 2005, 81(1):122-129.
31. Maki K.C., Reeves M.S., Farmer M., Yasunaga K., Matsuo N., Katsuragi Y., et al. Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. J Nutr 2009, 139(2):264-270.
32. Nagao T., Hase T., Tokimitsu I. A green tea extract high in catechins reduce body fat and cardiovascular risks in humans. Obesity (Silver Spring) 2007, 15(6):1473-1483.
33. Princen H.M., van Duyvenvoorde W., Buytenhek R., Blonk C., Tijburg L.B., Langius J.A., et al. No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol 1998, 18(5):833-841.
34. Batista Gde A., Cunha C.L., Scartezini M., von der Heyde R., Bitencourt M.G., Melo S.F. Prospective double-blind crossover study of Camellia sinensis (green tea) in dyslipidemias. Arq Bras Cadiol 2009, 93(2):128-134.
35. Frank J., George T.W., Lodge J.K., Rodriguez-Mateos A.M., Spencer J.P., Minihane A.M., et al. Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. J Nutr 2009, 139(1):58-62.
36. Chan C.C., Koo M.W., Ng E.H., Tang O.S., Yeung W.S., Ho P.C. Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome - a randomized placebo-controlled trial. J Soc Gynecol Investig 2006, 13(1):63-68.
37. Diepvens K., Kovacs E.M., Vogels N., Westerterp-Plantenga M.S. Metabolic effects of green tea and of phases of weight loss. Physiol Behav 2006, 87(1):185-191.
38. Freese R., Basu S., Hietanen E., Nair J., Nakachi K., Bartsch H., et al. Green tea extract decreases plasma malondialdehyde concentration but does not affect other indicators of oxidative stress, nitric oxide production, or hemostatic factors during a high-linoleic acid diet in healthy females. Eur J Nutr 1999, 38(3):49-157.
39. Fukino Y., Ikeda A., Maruyama K., Aoki N., Okubo T., Iso H. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Nutr 2008, 62(8):953-960.
40. Hsu C.H., Tsai T.H., Kao Y.H., Hwang K.C., Tseng T.Y., Chou P. Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr 2008, 27(3):363-370.
41. Nantz M.P., Rowe C.A., Bukowski J.F., Percival S.S. Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nutrition 2009, 25(2):147-154.
42. Brown A.L., Lane J., Coverly J., Stocks J., Jackson S., Stephen A., et al. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr 2009, 101(6):886-894.
43. Di Pierro F., Menghi A.B., Barreca A., Lucarelli M., Calandrelli A. Greenselect phytosome as an adjunct to a low-calorie diet for treatment of obesity. Altern Med Rev 2009, 14(2):154-160.
44. Eichenberger P., Colombani P.C., Mettler S. Effects of 3-week consumption of green tea extracts on whole-body metabolism during cycling exercise in endurance-trained men. Int J Vitam Nutr Res 2009, 79(1):24-33.
45. Bertipaglia de Santana M., Mandarino M.G., Cardoso J.R., Dichi I., Dichi J.B., Camargo A.E., et al. Association between soy and green tea (Camellia sinensis) diminishes hypercholesterolemia and increases total plasma antioxidant potential in dyslipidemic subjects. Nutrition 2008, 24(6):562-568.
46. Matsuyama T., Tanaka Y., Kamimaki I., Nagao T., Tokimitsu I. Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children. Obesity (Silver Spring) 2008, 16(6):1338-1348.
47. Takeshita M., Takashima S., Harada U., Shibata E., Hosoya N., Takase H., et al. Effects of longterm consumption of tea catechins-enriched beverage with no caffeine on body composition in humans. Jpn Pharmacol Ther 2008, 36(8):767-776. [in Japanese].
48. Inami S., Takano M., Yamamoto M., Murakami D., Tajika K., Yodogawa K., et al. Tea catechin consumption reduces circulating oxidized low-density lipoprotein. Int Heart J 2007, 48(6):725-732.
49. Ryu O.H., Lee J., Lee K.W., Kim H.Y., Seo J.A., Kim S.G., et al. Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract 2006, 71(3):356-358.
50. Erba D., Riso P., Bordoni A., Foti P., Biagi P.L., Testolin G. Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans. J Nutr Biochem 2005, 16(3):144-149.
51. van het Hof K.H., de Boer H.S., Wiseman S.A., Lien N., Westrate J.A., Tijburg L.B. Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 1997, 66(5):1125-1132.
52. Yach D., Hawkes C., Gould C.L., Hofman K.J. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 2004, 291(21):2616-2622.
53. Muramatsu K., Fukuyo M., Hara Y. Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J Nutr Sci Vitaminol (Tokyo) 1986, 32(6):613-622.
54. Fukuyo M., Hara Y., Muramatsu K. Effect of leaf catechin, (-)-epigallocatechin gallate, on plasma cholesterol level in rats. J Jpn Soc Nutr Food Sci 1986, 39(6):495-500. [in Japanese with English summary].
55. Matsuda H., Chisaka T., Kubomura Y., Yamahara J., Sawada T., Fujimura H., et al. Effects of crude drugs on experimental hypercholesterolemia. I. Tea and its active principles. J Ethnopharmacol 1986, 17(3):213-224.
56. Chan P.T., Fong W.P., Cheung Y.L., Huang Y., Ho W.K., Chen Z.Y. Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet. J Nutr 1999, 129(6):1094-1101.
57. Raederstorff D.G., Schlachter M.F., Elste V., Weber P. Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem 2003, 14(6):326-332.
58. Nakamura Y., Kaihara A., Yoshii K., Tsumura Y., Ishimitsu S., Tonogai Y. Effects of the oral administration of green tea polyphenol and tannic acid on serum and hepatic lipid contents and fecal steroid excretion in rats. J Health Sci 2001, 47(2):107-117.
59. Bose M., Lambert J.D., Ju J., Reuhl K.R., Shapses S.A., Yang C.S. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr 2008, 138(9):1677-1683.
60. Kobayashi M., Unno T., Suzuki Y., Nozawa A., Sagesaka Y., Kakuda T., et al. Heat-epimerized tea catechins have the same cholesterol-lowering activity as green tea catechins in cholesterol-fed rats. Biosci Biotechnol Biochem 2005, 69(12):2455-2458.
61. Yang T.T., Koo M.W. Chinese green tea lowers cholesterol level through an increase in fecal lipid excretion. Life Sci 2000, 66(5):411-423.
62. Yang M., Wang C., Chen H. Green oolong and black tea extracts modulate lipid metabolism in hyperlipidemia rats fed high-sucrose diet. J Nutr Biochem 2001, 12(1):14-20.
63. Miura Y., Chiba T., Tomita I., Koizumi H., Miura S., Umegaki K., et al. Tea catechins prevent the development of atherosclerosis in apolipoprotein E-deficient mice. J Nutr 2001, 131(1):27-32.
64. Vinson J.A., Teufel K., Wu N. Green and black teas inhibit atherosclerosis by lipid, antioxidant, and fibrinolytic mechanisms. J Agric Food Chem 2004, 52(11):3661-3665.
65. Chisaka T., Matsuda H., Kubomura Y., Mochizuki M., Yamahara J., Fujimura H. The effect of crude drugs on experimental hypercholesterolemia: mode of action of (-)-epigallocatechin gallate in tea leaves. Chem Pharm Bull (Tokyo) 1988, 36(1):227-233.
66. Ikeda I., Imasato Y., Sasaki E., Nakayama M., Nagao H., Takeo T., et al. Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim Biophys Acta 1992, 1127(2):141-146.
67. Löest H.B., Noh S.K., Koo S.I. Green tea extract inhibits the lymphatic absorption of cholesterol and α-tocopherol in ovariectomized rats. J Nutr 2002, 132(6):1282-1288.
68. Ikeda I., Kobayashi M., Hamada T., Tsuda T., Goto H., Imaizumi K., et al. Heat-epimerized tea catechins rich in gallocatechin gallate and catechin gallate are more effective to inhibit cholesterol absorption than tea catechins rich in epigallocatechin gallate and epicatechin gallate. J Agric Food Chem 2003, 51(25):7303-7307.
69. Ikeda I., Yamahira T., Kato M., Ishikawa A. Black-tea polyphenols decrease micellar solubility of cholesterol in vitro and intestinal absorption of cholesterol in rats. J Agric Food Chem 2010, 58(15):8591-8595.
70. Miyata Y., Tanaka T., Tamaya K., Matsui T., Tamaru S., Tanaka K. Cholesterol-lowering effect of black tea polyphenols, theaflavins, theasinensin A and thearubigins, in rats fed high fat diet. Food Sci technol Res 2011, 17(6):585-588.
71. Iqbal J., Hussain M.M. Intestinal lipid absorption. Am J Physiol Endocrinol Metab 2009, 296(1):E1183-E1194.
72. Altmann S.W., Davis H.R., Zhu L.J., Yao X., Hoos L.M., Tetzloff G., et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 2004, 303(5661):1201-1204.
73. Yu L., Bharadwaj S., Brown J.M., Ma Y., Du W., Davis M.A., et al. Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake. J Biol Chem 2006, 281(10):6616-6624.
74. Ge L., Wang J., Qi W., Miao H.H., Cao J., Qu Y.X., et al. The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1. Cell Metab 2007, 7(6):508-519.
75. Lee M.H., Lu K., Hazard S., Yu H., Shulenin S., Hidaka H., et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 2001, 27(1):79-83.
76. Lu K., Lee M.H., Hazard S., Brooks-Wilson A., Hidaka H., Kojima H., et al. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet 2001, 69(2):278-290.
77. Graf G.A., Li W.P., Gerard R.D., Gelissen I., White A., Cohen J.C., et al. Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. J Clin Invest 2002, 110(5):659-669.
78. Chen P.T., Lee M.J., Li H., Yang C.S. Absorption, distribution, and elimination of tea polyphenols in rats. Drug Metab Dispos 1997, 25(9):1045-1050.
79. Nakagawa K., Okuda S., Miyazawa T. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci Biotechnol Biochem 1997, 61(12):1981-1985.
80. Koo S.I., Noh S.K. Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. J Nutr Biochem 2007, 18(3):179-183.
81. Huggins K.W., Camarota L.M., Howles P.N., Hui D.Y. Pancreatic triglyceride lipase deficiency minimally affects dietary fat absorption but dramatically decreases dietary cholesterol absorption in mice. J Biol Chem 2003, 278(44):42899-42905.
82. Juhel C., Armand M., Pafumi Y., Rosier C., Vandermander J., Lairon D. Green tea extract (AR25) inhibits lipolysis of triglycerides in gastric and duodenal medium in vitro. J Nutr Biochem 2000, 11(1):45-51.
83. Ikeda I., Tsuda K., Suzuki Y., Kobayashi M., Unno T., Tomoyori H., et al. Tea catechins with a galloyl moiety suppress postprandial hypertriacylglycerolemia by delaying lymphatic transport of dietary fat in rats. J Nutr 2005, 135(2):155-159.
84. Nakai M., Fukui Y., Asami S., Toyoda-Ono Y., Iwashita T., Shibata H., et al. Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. J Agric Food Chem 2005, 53(11):4593-4598.
85. Kusano R., Ando H., Fujieda M., Tanaka T., Matsuo Y., Kouno I. Polymer-like polyphenols of black tea and their lipase and amylase inhibitory activities. Chem Pharm Bull 2008, 56(3):266-272.
86. Kobayashi M., Ichitani M., Suzuki Y., Unno T., Sugawara T., Yamahira T., et al. Black-tea polyphenols suppress postprandial hypertriacylglycerolemia by suppressing lymphatic transport of dietary fat in rats. J Agric Food Chem 2009, 57(15):7131-7136.
87. Unno T., Tago M., Suzuki Y., Nozawa A., Sagesaka Y.M., Kakuda T., et al. Effect of tea catechins on postprandial plasma lipid responses in human subjects. Br J Nutr 2005, 93(4):543-547.
88. Ikeda I., Matsuoka R., Hamada T., Mitsui K., Imabayashi S., Uchino A., et al. Cholesterol esterase accelerates intestinal cholesterol absorption. Biochim Biophys Acta 2002, 1571(1):34-44.
89. Hamada T., Ikeda I., Takashima K., Kobayashi M., Kodama Y., Inoue T., et al. Hydrolysis of micellar phosphatidylcholine accelerates cholesterol absorption in rats and Caco-2 cells. Biosci Biotechnol Biochem 2005, 69(9):1726-1732.
90. 2 and intestinal absorption of lipids in ovariectomized rats. J Nutr Biochem 2006, 17(7):492-498.
91. Vermeer M.A., Mulder T.P., Molhuizen H.O. Theaflavins from black tea, especially theaflavin-3-gallate, reduce the incorporation of cholesterol into mixed micelles. J Agric Food Chem 2008, 56(24):12031-12036.
92. Kajiya K., Kumazawa S., Nakayama T. Steric effects of interaction of tea catechins with lipid bilayers. Biosci Biotechnol Biochem 2001, 65(12):2638-2643.
93. Kumazawa S., Kajiya K., Naito A., Saito H., Tuzi S., Tanio M., et al. Direct evidence of interaction of a green tea polyohenol, epigallocatechin gallate, with lipid bilayers by solid-state nuclear magnetic resonance. Biosci Biotechnol Biochem 2004, 68(8):1743-1747.
94. Uekusa Y., Kamihira M., Nakayama T. Dynamic behavior of tea catechins interacting lipid membranes as determined by NMR spectroscopy. J Agric Food Chem 2007, 55(24):9986-9992.